The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites researchers to submit applications for multi-disciplinary diagnostic strategies for rare diseases that combine machine-assistance, genomic analysis, and clinical consultation. Of particular importance, these strategies must be able to be adopted and performed at the primary or secondary care levels by front-line healthcare providers and be readily integrated into their clinical care workflow.
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): April 19, 2021
RFA-TR-21-008 Expiration Date April 20, 2021
In view of the goals of this FOA, applicants should assemble a multi-disciplinary team with expertise in medical informatics, genetic analysis, rare diseases, and front-line healthcare when preparing the application.
Direct cost funding support may not exceed $200,000 per year for the UG3 phase of awards and $300,000 per year for the UH3 phase awards.